Black Diamond Therapeutics (BDTX) Profit After Tax: 2018-2021
Historic Profit After Tax for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to -$25.9 million.
- Black Diamond Therapeutics' Profit After Tax fell 14.32% to -$25.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$113.9 million, marking a year-over-year decrease of 69.31%. This contributed to the annual value of -$125.6 million for FY2021, which is 86.75% down from last year.
- Latest data reveals that Black Diamond Therapeutics reported Profit After Tax of -$25.9 million as of Q4 2021, which was up 26.26% from -$35.1 million recorded in Q3 2021.
- Over the past 5 years, Black Diamond Therapeutics' Profit After Tax peaked at -$3.1 million during Q4 2018, and registered a low of -$35.1 million during Q3 2021.
- For the 3-year period, Black Diamond Therapeutics' Profit After Tax averaged around -$17.6 million, with its median value being -$14.6 million (2020).
- Data for Black Diamond Therapeutics' Profit After Tax shows a maximum YoY tumbled of 222.08% (in 2019) over the last 5 years.
- Black Diamond Therapeutics' Profit After Tax (Quarterly) stood at -$3.1 million in 2018, then crashed by 222.08% to -$9.9 million in 2019, then slumped by 129.12% to -$22.6 million in 2020, then dropped by 14.32% to -$25.9 million in 2021.
- Its last three reported values are -$25.9 million in Q4 2021, -$35.1 million for Q3 2021, and -$30.3 million during Q2 2021.